NHS is expanding access to specialized care (Fampridine, endometriosis tests, morning-after pill) and improving women's health diagnostics (PMOS, maternity standards). However, data privacy concerns with Palantir and falling healthy life expectancy remain critical issues. Watch for updates on Palantir's data access and NICE's breast cancer screening criteria.